PAR-21-124 - Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Active NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)
Notice of Special Interest (NOSI): Advancing Research for Amyotrophic Lateral Sclerosis (ALS) NOT-NS-23-062 NINDS Feb 6, 2023 Jun 24, 2024 R61/R33, R41/R42, R43/R44

Expired NOSIs

Title Notice Number Organization Release
Date
Expiration
Date
Activity
Code(s)
Notice of Special Interest (NOSI): Discovery of Analgesic Natural Products through the NINDS IGNITE Program NOT-AT-20-016 NCCIH Aug 5, 2020 May 8, 2021 R61/R33


Technical Issues: E-mail OER Webmaster